Save
Bookmark
Print
| Sponsor Name | |
| Tumor Site | Small Cell Lung Cancer |
| Disease Stage | Stage IV |
| Clinical Status | |
| Phase | Phase III |
| Intervention / Treatment | Rovalpituzumab Teserine / Topotecan |
| Research Site | Montreal, QC, Sacré-Coeur Hospital |
| Investigator | Dr Kevin Jao |
| Telephone Number | 514-338-2222 ext 2818 |
| Study Start Date | February 23, 2017 |
| Study End Date | February 12, 2020 |
| Trial Status | Recruitment |
